Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vibeke Strand

Showing results (181-190 of 435) with videos related to

Pageof 44
Sort By:
The Journal of Rheumatology|December 17, 2017
Adiposity in Juvenile Psoriatic ArthritisAaida Samad, Matthew L Stoll, Idit Lavi, et al.
Frontiers in Medicine|September 22, 2018
Classification and Outcome Measures for Psoriatic ArthritisYing Ying Leung, Alexis Ogdie, Ana-Maria Orbai, et al.
BMJ Open|December 25, 2025
Sex differences in the efficacy, safety and persistence of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of phase III and long-term extension trialsVibeke Strand, Hendrik Schulze-Koops, Samar Al-Emadi, et al.
Arthritis Research & Therapy|November 14, 2009
Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year: results from the RAPID 1 randomized controlled trialVibeke Strand, Philip Mease, Gerd R Burmester, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|August 23, 2020
Pain and Fatigue in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors: Multinational Real-World FindingsVibeke Strand, Atul Deodhar, Rieke Alten, et al.
Rheumatology and Therapy|September 20, 2022
Routine Assessment of Patient Index Data 3 (RAPID3) in Patients with Rheumatoid Arthritis Treated with Long-Term Upadacitinib Therapy in Five Randomized Controlled TrialsMartin Bergman, Maya H Buch, Yoshiya Tanaka, et al.
Arthritis Research & Therapy|December 10, 2019
Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXTVibeke Strand, Janet Pope, Namita Tundia, et al.
Rheumatology (Oxford, England)|February 2, 2023
Long-term safety and efficacy of sarilumab with or without background csDMARDs in rheumatoid arthritisGerd R Burmester, Vibeke Strand, Alan J Kivitz, et al.
RMD Open|June 30, 2018
Impact of tocilizumab administered intravenously or subcutaneously on patient-reported quality-of-life outcomes in patients with rheumatoid arthritisVibeke Strand, Margaret Michalska, Christine Birchwood, et al.
Arthritis Research & Therapy|June 11, 2020
Correction to: Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXTVibeke Strand, Janet Pope, Namita Tundia, et al.
Pageof 44

Showing results (181-190 of 435) with videos related to

Sort By:
Pageof 44
The Journal of Rheumatology|December 17, 2017
Adiposity in Juvenile Psoriatic ArthritisAaida Samad, Matthew L Stoll, Idit Lavi, et al.
Frontiers in Medicine|September 22, 2018
Classification and Outcome Measures for Psoriatic ArthritisYing Ying Leung, Alexis Ogdie, Ana-Maria Orbai, et al.
BMJ Open|December 25, 2025
Sex differences in the efficacy, safety and persistence of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of phase III and long-term extension trialsVibeke Strand, Hendrik Schulze-Koops, Samar Al-Emadi, et al.
Arthritis Research & Therapy|November 14, 2009
Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year: results from the RAPID 1 randomized controlled trialVibeke Strand, Philip Mease, Gerd R Burmester, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|August 23, 2020
Pain and Fatigue in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors: Multinational Real-World FindingsVibeke Strand, Atul Deodhar, Rieke Alten, et al.
Rheumatology and Therapy|September 20, 2022
Routine Assessment of Patient Index Data 3 (RAPID3) in Patients with Rheumatoid Arthritis Treated with Long-Term Upadacitinib Therapy in Five Randomized Controlled TrialsMartin Bergman, Maya H Buch, Yoshiya Tanaka, et al.
Arthritis Research & Therapy|December 10, 2019
Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXTVibeke Strand, Janet Pope, Namita Tundia, et al.
Rheumatology (Oxford, England)|February 2, 2023
Long-term safety and efficacy of sarilumab with or without background csDMARDs in rheumatoid arthritisGerd R Burmester, Vibeke Strand, Alan J Kivitz, et al.
RMD Open|June 30, 2018
Impact of tocilizumab administered intravenously or subcutaneously on patient-reported quality-of-life outcomes in patients with rheumatoid arthritisVibeke Strand, Margaret Michalska, Christine Birchwood, et al.
Arthritis Research & Therapy|June 11, 2020
Correction to: Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXTVibeke Strand, Janet Pope, Namita Tundia, et al.
Pageof 44